Jonathan Krinsky, BTIG chief market technician, joins CNBC's Closing Bell to discuss market outlooks.

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

BTIG Research began coverage on shares of VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat.com reports. The brokerage set a ...

Energy and Infrastructure Transition Analyst Lewis holds a virtual meeting with management on November 22 hosted by BTIG. Don't Miss out on Research Tools: Discover the latest stocks recommended by ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

“Donald Trump cares about independent validators. And the biggest independent validator of his success is the market. It’s a ...

BSI-045B is also being advanced in multiple Phase 2 studies in China by Biosion’s regional partner, Chia Tai Tianqing ...

Plug Power (NASDAQ:PLUG) -1.1% in Thursday's trading as BTIG Research downgrades shares to Neutral from Buy, saying the company is "turning the corner but still [has] a lot of work to do." ...